Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
D000281:Administration, Intranasal; D000914:Antibodies, Viral / Q000032:analysis; D001826:Body Fluids / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009154:Mutation; D009297:Nasal Mucosa / Q000378:metabolism; D009976:Orthomyxoviridae Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D010033:Otitis Media / Q000209:etiology; D010614:Pharynx / Q000382:microbiology; D012136:Respiratory Syncytial Viruses / Q000276:immunology* / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D012220:Rhinitis / Q000209:etiology; D013696:Temperature; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000009:adverse effects; D014765:Viral Vaccines
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines